The aim of present study is to evaluate the efficacy and safety of two dose combination of
S-Amlodipine/Telmisartan (2.5/40mg amd 2.5/80mg) compared with S-Amlodipine monotherapy
(2.5mg) in hypertensive patients inadequately controlled by S-Amlodipine monotherapy.